Effect of Corticosteroid Injections on Blood Glucose

• Status: Not yet recruiting
• Trial end date: 2024-01-11
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to measure the effect of various corticosteroid formulations administered to the glenohumeral joint in diabetic patients on resultant blood glucose readings. In addition, the investigator is looking to quantify the effect of various corticosteroid formulations administered to the glenohumeral joint via ultrasound-guided injection on WORC and ASES scores in study patients.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Duke University
• Treatments: Betamethasone; Dexamethasone; Methylprednisolone; Methylprednisolone Acetate; Methylprednisolone Hemisuccinate; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate; Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

• Known diabetic patients ages 40-75 undergoing clinically indicated standard of care corticosteroid glenohumeral joint injection

• Ability to perform daily blood glucose testing

• Can receive and send text messages

Exclusion Criteria:

• Previous joint arthroplasty

• Corticosteroid injection at other sites in the body or in the shoulder within the past month

• Systemic corticosteroid within the last month other than asthma inhaler

• Anyone who are unable to read and/or understand English

• Pregnant women (self-report)

• Any clinical reason why any of the four medication options would not be safe or equally efficacious as the others